Pericoronary Adipocyte Size Gradient
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age30-90
SponsorInstitute for Clinical and Experimental Medicine
About this trial
Evaluation of pericoronary adipocyte gradient (PCAT) in relationship with local atherosclerotic changes in a patient undergoing heart transplantation.
Eligibility criteria
Qualifiers
Age 30-90 years
Diagnosis of dilatational or ischemic cardiomyopathy
Patients undergoing heart transplantation in IKEM
Disqualifiers
Known combined diagnosis of dilatational and ischemic cardiomyopathy
Arrhythmogenic cardiomyopathy
Congenital heart defects
Non-eligibility due to the absence of informed consent
Trial design
Treatments tested in this trial
- Heart transplantation for the final stage of heart failure
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov